Help for Alzheimer’s Disease.
More about ProMIS™ Neurosciences Inc.
The headquater of ProMIS™ Neurosciences, Inc. is in Toronto Ontario. Our offices is in Cambridge Massachusetts. ProMIS is a development stage biotechnology company. Our focus is on discovering and developing antibody therapeutics. It selectively targets the toxic oligomers. It is implicated in the development and progression. In particular, Alzheimer’s disease is amyotrophic lateral sclerosis and Parkinson’s disease.
For more information on ProMIS Neurosciences Inc. (PMN:TSX) please fill out the form below.